JG
CLVS

Jefferies Group’s Clovis Oncology, Inc. CLVS Stock Holding History

Jefferies Group’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-26,600
Closed -$128K – 2106
2020
Q4 		$128K Buy
+26,600
New +$135K ﹤0.01% 1432
2020
Q2 		– Sell
-50,000
Closed -$318K – 2191
2020
Q1 		$318K Sell
50,000
-30,000
-38% -$241K ﹤0.01% 1504
2019
Q4 		$834K Sell
80,000
-100,000
-56% -$727K 0.01% 1562
2019
Q3 		$707K Buy
+180,000
New +$1.46M 0.01% 1695
2019
Q2 		– Sell
-44,700
Closed -$1.11M – 2976
2019
Q1 		$1.11M Sell
44,700
-3,200
-7% -$80.2K 0.01% 1217
2018
Q4 		$860K Buy
47,900
+8,800
+23% +$180K 0.01% 1231
2018
Q3 		$1.15M Buy
+39,100
New +$1.51M 0.01% 1257
2017
Q3 		– Sell
-4,100
Closed -$384K – 2692
2017
Q2 		$384K Buy
+4,100
New +$251K ﹤0.01% 1738
2017
Q1 		– Sell
-34,100
Closed -$1.51M – 2735
2016
Q4 		$1.51M Hold
34,100
– – 0.01% 1059
2016
Q3 		$1.23M Sell
34,100
-41,000
-55% -$880K 0.01% 1181
2016
Q2 		$1.03M Sell
75,100
-6,500
-8% -$95K ﹤0.01% 1136
2016
Q1 		$1.57M Buy
81,600
+75,600
+1,260% +$1.6M 0.01% 959
2015
Q4 		$210K Hold
6,000
– – ﹤0.01% 1921
2015
Q3 		$552K Sell
6,000
-15,700
-72% -$1.36M ﹤0.01% 1466
2015
Q2 		$1.91M Buy
21,700
+11,700
+117% +$1M 0.01% 937
2015
Q1 		$742K Buy
+10,000
New +$706K ﹤0.01% 1202
2014
Q2 		– Sell
-6,900
Closed -$478K – 2464
2014
Q1 		$478K Buy
+6,900
New +$507K ﹤0.01% 1293
2013
Q4 		– Sell
-27,000
Closed -$1.64M – 2291
2013
Q3 		$1.64M Buy
+27,000
New +$1.91M 0.02% 686

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jefferies Group's CLVS Position: Q4 2021 in Review

Jefferies Group sold out of Clovis Oncology, Inc. (CLVS) in Q4 2021, closing a stake of 100,000 shares — an estimated $446K sold.

Jefferies Group first reported a position in CLVS in Q3 2013 and held it in 24 quarters. The position peaked at $2.39M in Q1 2014. 153 funds tracked by Wall St. Rank hold CLVS as of Q4 2021.

  • Jefferies Group reported no remaining Clovis Oncology, Inc. position as of Q4 2021 after selling out during the quarter.
  • Jefferies Group sold 100,000 Clovis Oncology, Inc. shares in Q4 2021, an estimated $446K.
  • Jefferies Group first reported a position in Clovis Oncology, Inc. in Q3 2013 and held it in 24 quarters.
  • Jefferies Group's Clovis Oncology, Inc. position peaked at $2.39M in Q1 2014.
  • 153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2021.

Based on Jefferies Group's 13F filing for Q4 2021, filed 14 Feb 2022.